Boston Scientific Corporation BSX

Set alert

Price alert · BSX

All alert types
44.32 USD +2.34 +5.57%

At close

44.25 -0.07 -0.16%

Pre-market · Nov 3, 5:18 AM ET

Bid
44.32 × 1
Ask
44.33 × 1
41.90 Day range 44.36
39.57 52-week range 105.65
YTD
-53.52%
1 year
-55.05%
Open
42.07
Prev close
41.98
Mkt cap
64.23B
Vol
22.71M
Avg vol
19.60M
EPS
2.37
P/E
18.70
Div yield
0.00%
More statistics
Low
41.90
High
44.36
Forward P/E
14.10
Beta
0.58
Short ratio
2.17
Inst. own
94.97%
Dividend
0.00
Ex-div date
Earnings
Feb 3, 2027
50-d avg
44.79
200-d avg
56.52
1y target
50.03

3M chart

Chart tools
Interval

Events in this range
  • Oct 28, 2026Earnings: 0.73; estimate 0.727; surprise 0.41%
  • Oct 29, 2026Rating: RBC Capital · Outperform → Outperform
  • Oct 29, 2026Rating: Bernstein · Outperform → Outperform
  • Oct 29, 2026Rating: Canaccord Genuity · Buy → Buy
  • Oct 29, 2026Downgrade: Jefferies · Buy → Hold
  • Oct 30, 2026Rating: Barclays · Equal-Weight → Equal-Weight
  • Oct 30, 2026Downgrade: TD Cowen · Buy → Hold
Signals (15)
NameDateAgo
SMA: BullishNov 2, 202619 hours ago
MACD: Sell SignalOct 29, 20264 days ago
SMA: BearishOct 28, 20265 days ago
SMA: BearishOct 27, 20266 days ago
SMA: BullishOct 22, 20261 week ago
SMA: BullishOct 15, 20262 weeks ago
MACD: Buy SignalOct 12, 20263 weeks ago
MACD: Sell SignalOct 2, 20261 month ago
MACD: Buy SignalSep 24, 20261 month ago
SMA: BearishSep 8, 20261 month ago
SMA: BearishSep 1, 20262 months ago
SMA: BullishAug 31, 20262 months ago
SMA: BearishAug 27, 20262 months ago
MACD: Sell SignalAug 24, 20262 months ago
RSI: OverboughtAug 11, 20262 months ago

Analyst view

Consensus: buy

Buy
Price target (mean) 50.03 +12.9% upside
Target (low)
41.00
Target (mean)
50.03
Target (high)
65.00
Ratings (0m) 31 20 buy · 11 hold · 0 sell
  • Strong buy6
  • Buy14
  • Hold11
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 31
  • 1 month ago 31
  • 2 months ago 31

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BSX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.775550.76864 – 0.790.80-3.1%5.18B-2.0%24
Next quarter0.744290.70 – 0.780.80-7.0%5.06B-2.7%17
Current year3.183.15 – 3.293.06+3.8%20.97B+4.4%28
Next year3.153.02 – 3.623.18-0.7%21.03B+0.3%29

Upgrades and downgrades

The latest rating changes

BSX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026TD CowenDowngradeBuyHold
Oct 30, 2026BarclaysMaintainedEqual-WeightEqual-Weight
Oct 29, 2026JefferiesDowngradeBuyHold
Oct 29, 2026Canaccord GenuityMaintainedBuyBuy
Oct 29, 2026BernsteinMaintainedOutperformOutperform
Oct 29, 2026RBC CapitalMaintainedOutperformOutperform
Oct 29, 2026CitigroupMaintainedNeutralNeutral
Oct 29, 2026Leerink PartnersMaintainedOutperformOutperform
Oct 29, 2026UBSMaintainedBuyBuy
Oct 29, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Oct 29, 2026BairdMaintainedOutperformOutperform
Oct 29, 2026BTIGMaintainedBuyBuy
Oct 28, 2026NeedhamMaintainedBuyBuy
Oct 26, 2026StifelMaintainedBuyBuy
Oct 14, 2026Truist SecuritiesMaintainedBuyBuy
Oct 7, 2026BarclaysInitiated—Equal-Weight
Oct 5, 2026CitigroupMaintainedNeutralNeutral
Sep 24, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Sep 21, 2026OppenheimerMaintainedOutperformOutperform
Sep 17, 2026CitigroupDowngradeBuyNeutral
Sep 9, 2026BTIGMaintainedBuyBuy
Aug 25, 2026TD CowenReiteratedBuyBuy
Jul 31, 2026Argus ResearchDowngradeBuyHold
Jul 30, 2026UBSMaintainedBuyBuy
Jul 30, 2026CitigroupMaintainedBuyBuy
Jul 30, 2026RBC CapitalMaintainedOutperformOutperform
Jul 30, 2026TD CowenMaintainedBuyBuy
Jul 30, 2026Canaccord GenuityMaintainedBuyBuy
Jul 30, 2026Truist SecuritiesMaintainedBuyBuy
Jul 30, 2026Evercore ISI GroupMaintainedOutperformOutperform